PAREXEL Announces Definitive Agreement To Acquire The Medical Affairs Company

PAREXEL press release ---- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, announced that the Company has entered into a definitive agreement to acquire The Medical Affairs Company, LLC ("TMAC"), a leading provider of outsourced medical affairs services to the pharmaceutical, biotechnology, and medical device industries. The acquisition is expected to close in February. Terms of the transaction were not disclosed. Founded in 2007, TMAC is a full-service contract medical organization. TMAC offers strategic and tactical medical science liaison (MSLs) and clinical nurse educator support services in addition to medical affairs consulting, medical communications support, and direct placement services. TMAC is based in Kennesaw, Georgia, and has approximately 200 U.S. based employees. Outsourcing medical affairs services presents a compelling option for biopharmaceutical companies as a way to reduce fixed costs. The increasingly complex nature of new products, and the need to demonstrate the therapeutic and reimbursement value of a product, is creating demand for credentialed healthcare professionals, such as MSLs, to lead clinically robust dialogues with key medical stakeholders on a peer-to-peer level. For more information on PAREXEL announcing definitive agreement to acquire The Medical Affairs Company click the picture below to read the release.